Zsolt M.
- Country
- Hungary
- Department
- 2027; Csecsemő, Gyermekgyógyászati és Neonatológiai osztály
Research Overview
- A 52-week randomized, double-blind, placebo-controlled, multi-center Phase 2b study with a 52-week blinded extension and an optional open-label extension—assessing the safety and efficacy of frexalimab, a CD40L-antagonist monoclonal antibody, for the preservation of pancreatic β-cell function in adults and adolescents with newly diagnosed type 1 diabetes on insulin therapy
- Evaluation of Efficacy, Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Glycopyrronium Bromide in Pediatric Asthma Patients Aged 6 to <12 Years
Data & Insights
Has run more than one trial at 3 of 68 partner sites.
Specializations
Diabetes Management
The investigator specializes in the study of Type 1 diabetes mellitus, with particular focus on innovative therapeutic approaches for newly diagnosed patients. Their research encompasses treatment strategies for both adults and adolescents.
- Endogenous insulin preservation
- Early-stage diabetes interventions
- Adolescent diabetes care
Their work explores therapeutic solutions that complement standard insulin therapy in diabetes management.
Therapeutic Innovation
The investigator's research focuses on evaluating novel therapeutic agents for autoimmune diabetes. Their work involves investigating treatments that may help maintain natural insulin production in patients with recent diabetes onset.
- Novel biological therapies
- Combination treatment approaches
- Long-term therapeutic outcomes
Their expertise extends to the assessment of innovative treatment modalities in conjunction with standard care protocols.
Youth Medicine
The investigator has developed specific expertise in adolescent medicine, particularly focusing on the treatment of young patients aged 12-21 years with diabetes. Their research addresses the unique challenges of managing diabetes in this age group.
- Adolescent-specific treatments
- Age-appropriate interventions
- Transitional care approaches
Their work emphasizes the importance of targeted therapeutic strategies for younger patient populations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.